Verastem, Inc. (VSTM)
4.24
-0.03
(-0.70%)
USD |
NASDAQ |
May 22, 16:00
4.24
0.00 (0.00%)
After-Hours: 20:00
Verastem Total Assets (Quarterly) : 227.81M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Altimmune, Inc. | 335.63M |
| Ocugen, Inc. | 56.90M |
| BioXcel Therapeutics, Inc. | 34.02M |
| Xilio Therapeutics, Inc. | 163.49M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 146.03M |
| Shareholders Equity (Quarterly) | 81.78M |
| Debt to Equity Ratio | 1.045 |
| Current Ratio | 3.035 |
| Net Debt Paydown Yield | -1.86% |